TipRanks

Matthew Gline Insider Profile

11 Followers
Matthew Gline, CEO, Director at Roivant Sciences, holds 16.55M shares in Roivant Sciences (Ticker: ROIV).
tipranks
Matthew Gline

Matthew Gline
Roivant Sciences (ROIV)
CEO, Director

Ranked #98,713 out of 109,349 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-40.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$611M
100.00%
A breakdown of Matthew Gline's holdings

Insider Roles

Roivant Sciences
(ROIV)
CEO, Director
Roles that Matthew Gline holds in companies

Most Profitable Insider Trade

Stock:
Roivant Sciences
(ROIV)
Rating:Informative Buy
Date:Sep 18, 2025 - Sep 18, 2026
Return:+50.40%
The most profitable trade made by Matthew Gline

Matthew Gline's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Roivant Sciences
Oct 20, 2026
CEO, Director
Uninformative Sell
1.16M
$610.83M
Success Rate for
ROIV
1 out of 5 profitable transactions on
ROIV
20%
Average Return for
ROIV
Average return per transaction on
ROIV
-40.10%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 31, 2023
Uninformative Buy
$250.01K
23,149
$10.80
―
Dec 17, 2025
Uninformative Buy
$47.06M
3,870,659
$12.15
―
Dec 28, 2022
Uninformative Sell
$137.80K
19,408
$7.10
―
May 25, 2023
Uninformative Sell
$181.75K
18,972
$9.58
―
Jun 26, 2023
Uninformative Sell
$108.74K
10,863
$10.01
―
List of latest transactions for each holding click on a transaction to see Matthew Gline's performance on stock

Matthew Gline insider profile FAQ

What is the percentage of profitable transactions made by Matthew Gline?
The percentage of profitable transactions made by Matthew Gline is 20%.
    What is the average return per transaction made by Matthew Gline?
    The average return per transaction made by Matthew Gline is -40.10%.
      What stocks does Matthew Gline hold?
      Matthew Gline holds: ROIV stocks.
        What was Matthew Gline’s latest transaction?
        Matthew Gline latest transaction was an Uninformative Sell of $1.16M.
          What was Matthew Gline's most profitable transaction?
          Matthew Gline’s most profitable transaction was an Informative Buy of ROIV stock on September 18, 2025. The return on the trade was 50.40%.
            What is Matthew Gline's role in Roivant Sciences?
            Matthew Gline's role in Roivant Sciences is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.